Delivery Order 36F79721D0239-36C24526N0779
Award Date 7/30/26
Potential Completion Date 8/4/26
Potential Value $33K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 5 issued a delivery order to Travere Therapeutics, Inc. on April 29, 2026, for $17,667.27 to supply Patient Medication Thiola 100mg for shipment to Clarksburg VA Medical Center's pharmacy. The order is issued under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a multiple-award indefinite delivery vehicle for rare disease pharmaceuticals. Place of performance is San Diego, CA. The ultimate completion date is May 1, 2026. Pricing is firm...
- This delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awards Travere Therapeutics, Inc. $10,915.75 to provide Thiola medication for patient use. Issued against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), this firm fixed price contract has a total small business set aside designation and is to be completed by December 22, 2022. The place of performance is in San Diego, California, where Travere Therapeutics...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $30,564.10 delivery order to Travere Therapeutics, Inc. for THIOLA 100 MG. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and performance period ending January 14, 2022 in San Diego, California. No set-aside designation was used for this order to supply the drug THIOLA to support healthcare services for...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $28,372.89 delivery order to Travere Therapeutics, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for the delivery of THIOLA 100 MG to a location in San Diego, California, with an expected completion date of October 18, 2021. No set-aside designation was used for this award made on October 15, 2021 to supply needed...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $28,380.95 delivery order to Travere Therapeutics, Inc. for THIOLA 100 MG. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and no set-aside designation. Performance will take place in San Diego, California by April 1st, 2022. The delivery order was awarded to supply thiol drugs to support treatment programs...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $12,000 delivery order to Travere Therapeutics, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is for THIOLA 100 MG and will be fulfilled by Travere Therapeutics, Inc. Division in San Diego, California over a three-day period from November 3rd through 6th, 2023. The contract has a firm fixed price and will support the VA-VHA's medical programs...
- The Department of Veterans Affairs' Veterans Integrated Service Network 5 (VISN 5) awarded a $28,975.20 delivery order to Travere Therapeutics, Inc. for the supply of Thiola 100 mg, a specialized pharmaceutical used to treat cystinuria and related kidney disorders. This award, issued on November 5, 2025, with an ultimate completion date of November 7, 2025, represents a firm fixed-price delivery order issued under Travere's existing Federal Supply Schedule contract for Pharmaceuticals and...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $17,988 delivery order to Travere Therapeutics, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. Travere Therapeutics will provide 100mg doses of the drug THIOLA to the VA medical center in San Diego, California between September 21-26, 2023. The firm fixed price order is being funded by VHA to support its mission of providing healthcare services to...
- Travere Therapeutics, Inc. was awarded a $25,983.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order, which has no set-aside designation, is for the delivery of 100 mg Thiola to the place of performance in San Diego, California. The order has a completion date of March 28, 2023 and was awarded on March 24, 2023 under Master GSA...
- Travere Therapeutics, Inc. has been awarded a $11,125.32 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to supply Thiola 100 MG pharmaceutical products. The delivery order was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) with no set-aside applied, and performance will occur in San Diego, California by March 12, 2024. Travere specializes in developing therapies for...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79721D0239Federal Supply Schedule
- 36F79721D0239-36C24526N0779Delivery Order
Veterans Integrated Service Network 5 issued a delivery order to Travere Therapeutics, Inc. on July 30, 2026, for Thiola 100 mg with a ceiling value of $33,371.51, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with ultimate completion on August 4, 2026. Place of performance is San Diego, CA. Travere Therapeutics supplies rare-disease pharmaceuticals to the Department of Veterans Affairs as a prime contractor and holds no subcontracting relationships on this award.
Generated 7/31/26, 9:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.4k | 7/29/26 |